News and Events
More News
-
WA’s innovation start-ups take off with WAVCI support 10 December 2025 Western Australia’s innovation ecosystem is gaining strength through the Western Australian Venture Capital Initiative (WAVCI), which has delivered strong results in its first year. The initiative is designed to expand the pool of venture capital available in WA and accelerate the growth of high-potential businesses across the State’s priority sectors. This funding will help founders access critical early-stage capital, enabling growth, commercialisation, and job creation. Seven venture capital funds have been appointed under the program: Artesian, Brandon Capital Partners and Health Translation Group will focus on health and medical opportunities, while Melt Ventures, Skalata Ventures, Purpose Ventures and FundWA will focus on other priority sectors for WA. All participating funds are establishing or expanding a WA presence, bringing new expertise, networks, and investment o... -
Nominate to become a FHRI Fund Advisory Council Member 05 December 2025 In accordance with theWestern Australian (WA) Future Health Research and Innovation (FHRI) Fund Act 2012 (the Act),the Minister for Medical Research invites expressions of interest (EOIs) from suitably qualified, WA based people, to fill the following two FHRI Fund Advisory Council Member vacancies: a member with experience dealing with issues related to the health of Aboriginal people living in WA a member with expertise in health and medical research in WA The Advisory Council plays a pivotal role advising the WA government on the strategic direction and funding allocations that drive health and medical research and innovation in WA. Established under Section 4G of the Act, the Advisory Council leads strategy and priority development for the FHRI Fund and provides expert recommendations and assurance to ensure transparent and strategically aligned investment in health and med... -
WA opens world-leading RNA facility to accelerate cancer research 03 December 2025 On 3 December 2025, Western Australia marked a major milestone in medical innovation with the official opening of the RNA Innovation Foundry (RIF) at The University of Western Australia (UWA). The new facility is set to fast-track the development of personalised RNA-based cancer treatments, positioning WA as a national leader in RNA research and precision medicine. The RIF is Australia’s first centre dedicated exclusively to applying RNA technology to oncology, designed to manufacture high-quality mRNA and expedite breakthroughs for aggressive and treatment-resistant cancers. Researchers, clinicians, and patient advocates will collaborate to design, produce, and test pilot RNA products, aiming to improve outcomes for a wide range of cancers. The Foundry was developed in partnership with the Australian Centre for RNA Therapeutics in Cancer (ACRTC) at UWA and is supported by a $6.8... -
8 DECEMBER 2025 | Spotlight on RHD information session 26 November 2025 The Office of Medical Research and Innovation (OMRI) invites prospective applicants to register for the Spotlight on Rheumatic Heart Disease (RHD) information session. The Spotlight Program is the centrepiece of the FHRI Fund Strategy 2025–30, providing up to $25 million to tackle a uniquely Western Australian health issue. The 2025–26 theme is RHD, with a focus on eliminating this preventable disease. Prospective applicants are encouraged to attend this virtual session to learn more about the program, funding process, and this year’s RHD focus. Date: Monday, 8 December 2025 Time: 1:00-1:45pm (UTC+08) Duration: 45 minutes (including Q&A) Registration is essential; only prospective applicants will receive the webinar link. Please submit questions when registering via TryBooking or via email at FHRI.Fund@health.wa.gov.au. Register here: TryBooki... -
WA to host 2026 World Congress on Rheumatic Heart Disease 26 November 2025 Perth will welcome the world’s leading experts in rheumatic heart disease (RHD) when it hosts the second World Heart Federation World Congress on RHD in November 2026. The event, announced by the Geneva-based World Heart Federation, will bring together researchers, health professionals, patients, advocates, and health leaders from around the globe to share practical solutions and strategies to help end RHD. The congress will be held at the Pan Pacific Perth from 12 to 14 November 2026 and is hosted by the Heart Foundation, with support from the Western Australian Government, the Leducq Foundation, the American Heart Association, the National Heart Foundation of New Zealand, Business Events Perth, and Business Events Australia. The announcement follows the recent launch of the Future Health Research and Innovation (FHRI) Fund Spotlight Program, which is dedicated this year to RHD. ...
Last Updated:
22/05/2025